MFDS
- Status: likely_approved
🇰🇷 Lucemyra in South Korea
Lucemyra (LOFEXIDINE) regulatory status in South Korea.
Marketing authorisation
Lucemyra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Lucemyra approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Lucemyra in South Korea?
Biocorrx Pharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.